RE: Gpl interview17 Dec 2024 12:33
Revenue 😀👍🏻
He noted the acquisition brings valuable talent and clinical-stage programs to Graft Polymer, positioning it for near-to-medium-term revenue generation. This move, Tennyson believes, significantly benefits Graft shareholders by providing a de-risked pipeline and growth opportunities.